Daclizumab Subcutaneous and Dialyvite

• Generic Name: daclizumab
• Dosage Forms: n.a.
• Other Brand Names: Zinbryta, Zenapax

Daclizumab injection is used to treat the relapsing forms of multiple sclerosis (MS). Daclizumab will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used when other medicines to treat MS did not work well.

Daclizumab was available only under a restricted distribution program called the Zinbryta® REMS (Risk Evaluation and Mitigation Strategy) Program.

Daclizumab was voluntarily withdrawn from the worldwide market on March 2, 2018 due to safety concerns.

• Generic Name: multivitamin with iron
• Dosage Forms: tablet, coated
• Other Brand Names:

  Fero-Folic 500, Theragran Hematinic, Ultra Enerforce

Diacomit (stiripentol) is a prescription medicine used to treat seizures associated with Dravet syndrome. Dravet syndrome is a rare chronic form of epilepsy that begins in the first year of life and causes frequent or prolonged seizures.

Diacomit is used along with clobazam for use in adults and children at least 2 years old.

It is not known if Diacomit is safe and effective in children under 2 years of age.

There is no clinical data to support the use of Diacomit alone to treat Dravet syndrome.